Closmann James J
Tripler Army Medical Center, Hawaii, USA.
Gen Dent. 2007 May-Jun;55(3):252-4; quiz 255, 264.
High-risk human papilloma virus (HPV) strains 16 and 18 have been shown to cause cervical cancer as well as other benign and malignant disorders. Oral and oropharyngeal squamous cell carcinoma (OOSCC) has been linked to high-risk HPV strains. Recent developments in the field of immunology have resulted in a vaccine to treat patients with HPV against cervical cancer. The widespread use of the HPV vaccine should reduce the risk of cervical cancer and could decrease the risk of OOSCC as well. This article examines the virus as well as the vaccines and how they could be used. A possible reduction in oral and oropharyngeal cancers as a result of widespread vaccination is discussed.
高危型人乳头瘤病毒(HPV)16型和18型已被证实可引发宫颈癌以及其他良性和恶性疾病。口腔和口咽鳞状细胞癌(OOSCC)与高危型HPV毒株有关。免疫学领域的最新进展催生了一种用于治疗HPV感染患者以预防宫颈癌的疫苗。HPV疫苗的广泛使用应能降低患宫颈癌的风险,也可能降低患口咽鳞状细胞癌的风险。本文探讨了该病毒以及疫苗,以及它们的使用方式。还讨论了广泛接种疫苗可能导致口腔和口咽癌发病率降低的情况。